Simultaneous Imaging and Drug Delivery for Prostate Cancer Theranostics [ 2013 - 2016 ]

Research Grant

Researchers: Prof Pamela Russell (Principal investigator) ,  A/Pr Kristofer Thurecht ,  Prof Andrew Whittaker

Brief description Prostate cancer (PC) is the most common cancer in men over 50. The answers to the key questions in advanced PC (Who to treat, and how to treat: loco-regionally or systemically?) rest with clinical staging – something that has hitherto been very imprecise. We have generated a highly-sensitive 19F-molecular imaging agent which could help resolve both questions and create a targeted therapy, diminishing the burden of harm of today’s therapies by using nanoparticles to diagnose and treat PC.

Funding Amount $AUD 565,205.48

Funding Scheme Project Grants

Notes Standard Project Grant